Investors poured money into AI-focused drug discovery businesses in 2020. While critical during the pandemic, breakthroughs may be replicated in other areas of medicine in the years ahead. AFP
Investors poured money into AI-focused drug discovery businesses in 2020. While critical during the pandemic, breakthroughs may be replicated in other areas of medicine in the years ahead. AFP

5 takeaways from Stanford’s new AI index